CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Preferred Stock, Shares Authorized from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Charles River Laboratories International, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q2 2010 to Q2 2024.
  • Charles River Laboratories International, Inc. Preferred Stock, Shares Authorized for the quarter ending June 29, 2024 was 20M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 20M 0 0% Jun 29, 2024 10-Q 2024-08-07
Q1 2024 20M 0 0% Mar 30, 2024 10-Q 2024-05-09
Q4 2023 20M 0 0% Dec 30, 2023 10-Q 2024-08-07
Q3 2023 20M 0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 20M 0 0% Jul 1, 2023 10-Q 2023-08-09
Q1 2023 20M 0 0% Apr 1, 2023 10-Q 2023-05-11
Q4 2022 20M 0 0% Dec 31, 2022 10-K 2024-02-14
Q3 2022 20M 0 0% Sep 24, 2022 10-Q 2022-11-02
Q2 2022 20M 0 0% Jun 25, 2022 10-Q 2022-08-03
Q1 2022 20M 0 0% Mar 26, 2022 10-Q 2022-05-04
Q4 2021 20M 0 0% Dec 25, 2021 10-K 2023-02-22
Q3 2021 20M 0 0% Sep 25, 2021 10-Q 2021-11-03
Q2 2021 20M 0 0% Jun 26, 2021 10-Q 2021-08-04
Q1 2021 20M 0 0% Mar 27, 2021 10-Q 2021-05-04
Q4 2020 20M 0 0% Dec 26, 2020 10-K 2022-02-16
Q3 2020 20M 0 0% Sep 26, 2020 10-Q 2020-11-09
Q2 2020 20M 0 0% Jun 27, 2020 10-Q 2020-08-05
Q1 2020 20M 0 0% Mar 28, 2020 10-Q 2020-05-07
Q4 2019 20M 0 0% Dec 28, 2019 10-K 2021-02-17
Q3 2019 20M 0 0% Sep 28, 2019 10-Q 2019-11-06
Q2 2019 20M 0 0% Jun 29, 2019 10-Q 2019-07-31
Q1 2019 20M 0 0% Mar 30, 2019 10-Q 2019-05-07
Q4 2018 20M 0 0% Dec 29, 2018 10-K 2020-02-11
Q3 2018 20M 0 0% Sep 29, 2018 10-Q 2018-11-07
Q2 2018 20M 0 0% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 20M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 20M 0 0% Dec 30, 2017 10-K 2019-02-13
Q3 2017 20M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 20M 0 0% Jul 1, 2017 10-Q 2017-08-09
Q1 2017 20M 0 0% Apr 1, 2017 10-Q 2017-05-10
Q4 2016 20M 0 0% Dec 31, 2016 10-K 2018-02-13
Q3 2016 20M 0 0% Sep 24, 2016 10-Q 2016-11-02
Q2 2016 20M 0 0% Jun 25, 2016 10-Q 2016-08-03
Q1 2016 20M 0 0% Mar 26, 2016 10-Q 2016-05-04
Q4 2015 20M 0 0% Dec 26, 2015 10-K 2017-02-14
Q3 2015 20M 0 0% Sep 26, 2015 10-Q 2015-11-04
Q2 2015 20M 0 0% Jun 27, 2015 10-Q 2015-07-30
Q1 2015 20M 0 0% Mar 28, 2015 10-Q 2015-04-30
Q4 2014 20M 0 0% Dec 27, 2014 10-K 2016-02-12
Q3 2014 20M 0 0% Sep 27, 2014 10-Q 2014-10-30
Q2 2014 20M 0 0% Jun 28, 2014 10-Q 2014-08-07
Q1 2014 20M Mar 29, 2014 10-Q 2014-04-30
Q4 2013 20M 0 0% Dec 28, 2013 10-K 2015-02-17
Q3 2013 20M Sep 28, 2013 10-Q 2013-10-30
Q2 2013 20M Jun 29, 2013 10-Q 2013-07-31
Q4 2012 20M 0 0% Dec 29, 2012 10-Q 2013-10-30
Q1 2012 20M 0 0% Mar 31, 2012 10-Q 2013-05-08
Q4 2011 20M 0 0% Dec 31, 2011 10-Q 2013-05-08
Q3 2011 20M 0 0% Sep 24, 2011 10-Q 2011-11-02
Q2 2011 20M 0 0% Jun 25, 2011 10-Q 2011-08-03
Q1 2011 20M Mar 26, 2011 10-Q 2011-05-04
Q4 2010 20M Dec 25, 2010 10-K 2012-02-27
Q3 2010 20M Sep 25, 2010 10-Q 2010-11-04
Q2 2010 20M Jun 26, 2010 10-Q 2010-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.